Dr. Tomoji Yanagita passed away in Tokyo on 31 July 2016 after an extended illness. He is survived by his family, his wife, Teruko, and his three daughters: Yuriko, Noriko, and Kiyoko. He graduated from the Jikei University in Tokyo, Japan and received his medical degree in 1956 and his doctorate degree on the acute toxicity of ephedrines in 1961. Dr. Yanagita was an unassuming, very strong supporter of psychopharmacology with a special interest in the pharmacology of drugs that led to their abuse. He came to this aspect of pharmacology from his exposure to Dr. Maurice Seevers, primates, and opioid pharmacology as a Fulbright fellow from 1960 to 1965 in the Department of Pharmacology at the University of Michigan. He and his colleagues published a seminal paper on the implementation of intravenous drug self-administration in rhesus monkeys in this journal (1969: 16, 30-48) . Several of the elements of the discoveries described in the paper are important to an understanding of the rest of his career in psychopharmacology.
When Dr. Yanagita came to Ann Arbor, Dr. Seevers was the Chair of the Department of Pharmacology. Dr. Seevers had established a strong relationship to Japanese pharmacology as an advisor on ways of curbing drug abuse problems in Japan after the World War II. Many young pharmacologists came to study various aspects of pharmacology in the department, and Dr. Yanagita was eager but undeveloped in his intereststhough he had plenty of skills that led in productive directions. Dr. Yanagita enjoyed telling the story of how Dr. Seevers shaped the subject and direction of his efforts during his stay. Dr. Seevers had a large, ongoing research program on opiatedependence assessment in primates, and he suggested to Tomoji that he should work with Dr. Gerald Deneau in rhesus monkeys to develop drug self-administration studies without having a specific application in mind.
They started with a large number of oral opioids, including the potent morphine-like narcotic etonitazene, as substances that might be effective on ingestion of small volumes. After some time without outstanding success, Drs. Deneau and Yanagita took a short trip to the Upjohn Company in Kalamazoo to visit Dr. James Weeks, a recent Michigan pharmacology graduate. Dr. Weeks, who had a reputation as a Bgadgeteer,^had reported success with a procedure for intravenous drug self-administration in rats and had published an important paper on the topic in Science (1962: 138, 143-144) . Drs. Yanagita and Deneau returned to Ann Arbor, and with extensive consults with Dr. Seevers, designed a restraint device that allowed intravenous drug delivery that was described in detail in the 1969 paper mentioned above. Interestingly, Dr. Weeks published a follow-up paper in Scientific American (1964: 210, 46-52) that described pictorially the rhesus monkey preparation in Ann Arbor. By this time, the technique and restraint device was working well in monkeys.
The data in the 1969 paper can be distilled to the notion that rhesus monkeys self-administered many of the drugs that humans abuse. Dr. Yanagita described in a symposium honoring Dr. Seevers's retirement, early findings with the technique that they invented together (Michigan Medical Center Journal, 1970: 36, 216-224) . So the three of them, and subsequently many pharmacologists and psychologists that followed, revolutionized the experimental study on drugs of abuse and opened a general field of study-the reinforcing effects of drugs-that continues today to focus the scientific attention of investigators throughout the world.
Dr. Yanagita returned to Japan in 1965, and with the aid of a subcontract from Dr. Seevers' NIH grant, he developed a primate research laboratory for the study of drug dependence in rhesus monkeys at the Central Institute for Experimental Animals in Kawasaki. He focused his studies on the capacity of drugs to serve as reinforcers in relation to other aspects of their pharmacology. For example, he made many seminal findings on abuse liability of sedative drugs and new antianxiety agents being considered for human use. He also developed devices for the study of drugs in novel ways, e.g., the intranasal delivery of drugs to the airway (Japanese Journal of Clinical Pharmacology and Therapeutics 1970: 1, 13-16) and a smoking device in this journal (1981: 72, 117-127) , both for rhesus monkeys. He maintained and expanded his laboratory by making it the first contract research laboratory in Japan for pharmacological and toxicological studies.
Dr. Yanagita was throughout his professional career a leader in scientific fields and organizations related to pharmacology in Japan and internationally. By the time he returned to Japan, many of these fields and organizations were in a budding phase and it was a logical extension for him to become deeply involved in their initial establishment and subsequent growth. The scientific societies in Japan in which he played key roles included the Japanese Medical Society of Alcohol and Drug Dependence (established in 1965; currently the Japanese Medical Society of Alcohol and Addiction Studies), the Japanese Society of Neuropsychopharmacology (more formally established in 1985, but started as a small study group in 1971), the Japanese Toxicology Society (formally established in 1981; started as a small study group in 1973), the Japanese Clinical Pharmacology Society ( Dr. Yanagita was a person who was at the right place at the right moment in time, with certain capacities and characteristics, and who took his opportunities and applied his talents to significantly advance science and public health worldwide. He was original to us, and he will be missed by all. James H. Woods University of Michigan Kohji Takada Teikyo University
